Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Scientists want this CRISPR pill to one day replace antibiotics

Add as a preferred source on Google

Scientists from the University of Wisconsin-Madison want to stamp out antibiotic-resistant bacteria. Their weapons of choice are deception and a powerful gene-editing tool called CRISPR.

CRISPR has been making waves over the past few years, leading to what some are calling the “CRISPR Revolution,” impacting industries from healthcare to agriculture. Initially borrowed from bacteria, which use CRISPR as an immune defense against viruses, the gene-editing tool works by recording snippets of the attacker’s DNA, so that the bacteria can recognize and eliminate future invaders.

Genome Editing with CRISPR-Cas9

In his lab at the University of Wisconsin-Madison, Jan-Peter Van Pijkeren hopes to use CRISPR to deceive a nasty germ called Clostridium difficile. It may sound unfamiliar to most people but it’s nonetheless a risk to hospital patients. Studies have shown C. difficile to be the cause of almost half a million infections and 15,000 deaths in the United States, topping the U.S. Centers for Disease Control and Prevention’s list of drug-resistant threats.

Recommended Videos

Van Pijkeren’s plan is to develop a virus that can carry a customized CRISPR message into the human body by packaging it into a swallowable probiotic pill. When the pill passes into a person’s intestinal tract, the virus would exit and infect any C. difficile in the area, delivering a false message that causes the bacteria to self-destruct. Though the pill hasn’t yet been tested in animals, previous studies have shown that similar methods work, reports MIT Technology Review.

Sweeping antibiotic use — which kills off both good and bad bacteria — sets the stage for drug-resistant bacteria. As such, C. difficile will be a persistent problem, according to Herbert DuPont, director of the Center for Infectious Diseases at the University of Texas. “As long as we house patients together in a hospital or in a nursing home and we give a lot of them antibiotics we’re going to have a problem with C. difficile,” he told Technology Review. Research into other methods to eliminate harmful bacteria are desired, even if it may take years before they replace today’s antibiotics.

Dyllan Furness
Former Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Hyundai isn’t giving up on hydrogen cars, but don’t expect one in your driveway anytime soon
Hydrogen gets a maybe; hybrids get a warning.
Hyundai Ioniq 3 EV

Hydrogen cars have spent years in the same waiting room as flying taxis. They’re always almost here, but no commercially available product exists for interested buyers. So when a Hyundai manager pushed back on the obituary, I was immediately curious.

To be clear, Hyundai hasn’t announced a new car. The big news here is that its Australian arm says hydrogen is “not dead” for passenger cars. Apparently, the automaker is still evaluating a next-generation hydrogen fuel-cell car if it can find buyers (via CarExpert).

Read more
AI doesn’t have to turn evil to put you at risk 
emo-robot-that-can-lip-sync

An AI assistant that agrees with everything you say might feel like the perfect companion — until you need someone to tell you you’re wrong. That’s one of the more immediate dangers behind the idea of AI “going rogue.” A chatbot can cause harm without developing intentions of its own. It can reinforce a false belief, encourage an unhealthy attachment, or follow instructions planted by someone trying to hijack it.   

On October 15, AI safety company Alice announced new software to address those everyday risks. Working separately with Inflection AI and AI21, the company says it helped train NVIDIA’s Nemotron models to resist harmful conversational behavior and malicious instructions while preserving their usefulness.  

Read more
Elon Musk says Neuralink’s brain implants could help people with paralysis and blindness
Neuralink's Telepathy helps people control computers through thought, while Blindsight aims to restore visual perception.
elon-musk-neuralink-brain-implant

Elon Musk has revealed ambitious plans for Neuralink, and they go beyond controlling computers with your thoughts. The company is developing two brain implants, Telepathy and Blindsight, aimed at helping people with paralysis and severe vision loss. Musk also believes future advances could help people regain control of their hands and legs by reconnecting the brain with their limbs.

How Neuralink's Telepathy can help people with paralysis

Read more